|
US4559157A
(en)
|
1983-04-21 |
1985-12-17 |
Creative Products Resource Associates, Ltd. |
Cosmetic applicator useful for skin moisturizing
|
|
LU84979A1
(fr)
|
1983-08-30 |
1985-04-24 |
Oreal |
Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
|
|
DE3441788A1
(de)
|
1984-11-15 |
1986-05-15 |
Bayer Ag, 5090 Leverkusen |
Alkyl-1-cyclopropyl-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
|
|
US4820508A
(en)
|
1987-06-23 |
1989-04-11 |
Neutrogena Corporation |
Skin protective composition
|
|
US4992478A
(en)
|
1988-04-04 |
1991-02-12 |
Warner-Lambert Company |
Antiinflammatory skin moisturizing composition and method of preparing same
|
|
US4938949A
(en)
|
1988-09-12 |
1990-07-03 |
University Of New York |
Treatment of damaged bone marrow and dosage units therefor
|
|
US5962731A
(en)
|
1992-04-22 |
1999-10-05 |
Ligand Pharmaceuticals Incorporated |
Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
|
|
US5780676A
(en)
|
1992-04-22 |
1998-07-14 |
Ligand Pharmaceuticals Incorporated |
Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
|
|
ATE195716T1
(de)
|
1992-04-22 |
2000-09-15 |
Ligand Pharm Inc |
Retinoid-x rezeptor selektive verbindungen
|
|
US7655699B1
(en)
|
1992-04-22 |
2010-02-02 |
Eisai Inc. |
Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
|
|
US6137002A
(en)
|
1993-07-22 |
2000-10-24 |
Eli Lilly And Company |
Glycoprotein IIb/IIIa antagonists
|
|
WO1997012853A1
(en)
*
|
1995-10-06 |
1997-04-10 |
Ligand Pharmaceuticals Incorporated |
Dimer-selective rxr modulators and methods for their use
|
|
FR2746101B1
(fr)
*
|
1996-03-14 |
1998-04-30 |
|
Composes bicycliques-aromatiques
|
|
WO1998046076A1
(en)
*
|
1997-04-11 |
1998-10-22 |
Sidney Kimmel Cancer Center |
Retinoid related molecules for the inhibition of endothelin-1 overproduction in disease
|
|
FR2776657B1
(fr)
*
|
1998-03-31 |
2000-05-26 |
Cird Galderma |
Composes bicycliques-aromatiques et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetologie
|
|
KR100538417B1
(ko)
*
|
1998-05-06 |
2005-12-22 |
갈데르마 리써어치 앤드 디벨로프먼트,에스.엔.씨. |
멜라닌 생성을 촉진하는 화합물의 확인을 위한 분석법 및그 분석법에 의해 확인되는 레티노이드류 화합물
|
|
ATE365158T1
(de)
*
|
1999-04-28 |
2007-07-15 |
Inst Med Molecular Design Inc |
Pyrimidincarbonsäurederivate
|
|
US6313107B1
(en)
|
2000-08-29 |
2001-11-06 |
Allergan Sales, Inc. |
Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
|
|
US6291677B1
(en)
|
2000-08-29 |
2001-09-18 |
Allergan Sales, Inc. |
Compounds having activity as inhibitors of cytochrome P450RAI
|
|
ES2256288T3
(es)
|
2000-08-29 |
2006-07-16 |
Allergan, Inc. |
Compuestos con actividad como inhibidores de citocromo p450rai.
|
|
US6303785B1
(en)
|
2000-08-29 |
2001-10-16 |
Allergan Sales, Inc. |
Compounds having activity as inhibitors of cytochrome P450RAI
|
|
ZA200504898B
(en)
|
2002-12-20 |
2006-11-29 |
Pharmacia Corp |
Acyclic pyrazole compounds
|
|
WO2005013949A2
(en)
*
|
2003-08-07 |
2005-02-17 |
Allergan, Inc. |
Method for treating cachexia with retinoid ligands
|
|
EP1541549A1
(en)
|
2003-12-12 |
2005-06-15 |
Exonhit Therapeutics S.A. |
Tricyclic hydroxamate and benzaminde derivatives, compositions and methods
|
|
US7226951B2
(en)
|
2003-12-17 |
2007-06-05 |
Allergan, Inc. |
Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same
|
|
WO2005058301A1
(en)
|
2003-12-17 |
2005-06-30 |
Allergan, Inc. |
Methods for treating retinoid responsive disorders using selective inhibitors of cyp26a and cyp26b
|
|
WO2007022437A2
(en)
*
|
2005-08-18 |
2007-02-22 |
Auspex Pharmaceuticals, Inc. |
Therapeutic agents for the treatment of cancer and metabolic disorders
|
|
EP2130908A3
(en)
*
|
2006-08-29 |
2010-01-06 |
Reinnervate Limited |
Retinoid compounds and their use
|
|
HUE031712T2
(en)
|
2007-01-15 |
2017-08-28 |
Chongxi Yu |
Retinoids and retinoid-like compounds with positively charged water-soluble prodrugs having very high skin penetration rates
|
|
WO2010096264A2
(en)
|
2009-02-03 |
2010-08-26 |
Children's Medical Center Corporation |
Methods for enhancing hematopoietic stem/progenitor cell engraftment
|
|
WO2011006157A2
(en)
*
|
2009-07-10 |
2011-01-13 |
Case Western Reserve University |
Rxr agonist compounds and methods
|
|
US9096544B2
(en)
*
|
2009-12-23 |
2015-08-04 |
Wayne State University |
Therapeutic compounds
|
|
CA2790318A1
(en)
|
2010-02-19 |
2011-08-25 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acti Ng For And On Behalf Of Arizona State University |
Novel bexarotene analogs
|
|
JP5743129B2
(ja)
|
2010-04-16 |
2015-07-01 |
Dic株式会社 |
重合性化合物を含有する液晶組成物及びそれを使用した液晶表示素子
|
|
CA2848540A1
(en)
|
2011-09-15 |
2013-03-21 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University |
Therapeutic compounds
|